Identifying 10-year cumulative incidence and risk of revision following total hip arthroplasty in patients with and without a diagnosis of human immunodeficiency virus
Surgeons and patients can be reassured of comparable 10-year revision rates in patients with and without HIV. However, as these patients are at increased risk for PJI and PPF, especially those with AIDS, when compared to the general population, surgeons should consider PJI prophylactic modalities in this patient population.
Authors
- Sonal Mahindroo (ORCID: https://orcid.org/0000-0002-2916-1022)
- Jordan Cohen (ORCID: https://orcid.org/0000-0003-2318-1521)
- Samantha Ferraro
- Amy Y. Zhao (ORCID: https://orcid.org/0000-0002-0494-4223)
- Amil R. Agarwal (ORCID: https://orcid.org/0000-0002-0480-9515)
- Gregory J. Golladay (ORCID: https://orcid.org/0000-0003-0956-7559)
- Avilash Das (ORCID: https://orcid.org/0000-0002-0445-0012)
- Savyasachi C. Thakkar (ORCID: https://orcid.org/0000-0003-2470-8970)
Institutions
- Johns Hopkins University (US)
- Virginia Commonwealth University (US)
- George Washington University (US)
- Johns Hopkins Medicine (US)
- University of Pennsylvania Health System (US)
Publication Details
- Journal
- Hip International
- Published
- 2024-12-18
- DOI
- https://doi.org/10.1177/11207000241307309
- Primary Topic
- Orthopaedic implants and arthroplasty
- Type
- article
- Field-Weighted Citation Impact
- 0.00